Standard BioToolsLAB

那斯達克 · USD
1.48
+0.01
(+0.68%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.28
  • 0.25
  • 0.28
  • 0.46
  • 0.37
  • 0.45
  • 1.08
  • 0.41
  • 0.01
  • 0.20
icon
  • 10.14
  • -8.31
  • 11.12
  • 61.56
  • -18.30
  • 20.87
  • 140.61
  • -12.68
  • -97.09
  • 1544.41
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
19,552
1,189
40,795
108,201
44,969
37,205
45,540
28,188
25,367
27,666
營業成本
10,068-74721,05457,46521,70822,29721,35214,83114,15714,008
營業毛利
9,484
1,936
19,741
50,736
23,261
14,908
24,188
13,357
11,210
13,658
營業費用
42,42221,63352,711124,56954,97965,42784,37034,74332,38231,107
研發費用
6,35633411,32840,62013,15619,22215,9806,9096,4266,240
推銷及管理費用
26,63819,57239,83183,82339,48240,45664,10626,17323,95822,600
非經常性項目費用
9,4281,7271,5521262,3415,7494,2841,6611,9982,267
其他營業費用
----------
營業利益
-32,938
-19,697
-32,970
-73,833
-31,718
-50,519
-60,182
-21,386
-21,172
-17,449
其他收入及費用
484,1196,788-4114,8983,82328,1536,0153,6942,956
利息費用
1092572--1,033-4,5673,4692,246
稅前純益
-32,900
-15,587
-26,184
-74,816
-26,820
-45,663
-32,029
-19,938
-20,947
-16,739
所得稅
-1,216-577-15130311855128-16250301
稅後純益
-34,687
-33,459
-26,033
-34,072
-26,938
-45,718
-32,157
-19,776
-20,997
-17,040
基本每股稅後盈餘(元)
-0.09-0.09-0.07-0.09-0.07-0.12-0.27-0.25-0.27-0.22
稀釋每股稅後盈餘(元)
-0.09-0.09-0.07-0.08-0.07-0.10-0.27-0.25-0.26-0.22
基本平均股數(千股)
382630.00380498.00378228.00374544.00371538.00372331.00294125.0079729.0079152.0078669.00
稀釋平均股數(千股)
382630.00380498.00378228.00374544.00371538.00372331.00294125.0079729.0079152.0078669.00
還原基本每股稅後盈餘(元)
-0.09-0.09-0.07-0.09-0.07-0.12-0.27-0.25-0.27-0.22
還原稀釋每股稅後盈餘(元)
-0.09-0.09-0.07-0.08-0.07-0.10-0.27-0.25-0.26-0.22
還原基本平均股數(千股)
382,630380,498378,228374,544371,538372,331294,12579,72979,15278,669
還原稀釋平均股數(千股)
382,630380,498378,228374,544371,538372,331294,12579,72979,15278,669
EBITDA(千元)
-34,983-30,763-22,852-30,376-24,721-44,724-29,495-10,374-12,744-10,292

大家都在看

HOT